«Running prevents postnatal side effects
of epilepsy drugs in mice.»
Britain's competition watchdog has fined Pfizer a record 84.2 million pounds ($ 107 million) for its role in ramping up the cost
of an epilepsy drug by as much as 2,600 %.
2018-04-06: Two lots
of the epilepsy drug Primidone recalled because of high levels of lead, which may pose serious health risks
Volunteers who ate veggies grown in wastewater had higher (but still safe) levels
of an epilepsy drug in their urine, compared with subjects who ate freshwater - grown veggies.
Not exact matches
It is now possible to treat
epilepsy and schizophrenia (madness) using a herbal
drug discovered by a Nigerian Scholar
of Pharmacology and Toxicology
of Kaduna state...
The study — led by James Murrough, associate professor
of psychiatry and director
of the Mood and Anxiety Disorders Program at Mount Sinai — chose the
epilepsy drug ezogabine, which was given to 18 patients in a pilot trial.
It is a minimally invasive procedure that is proving to be a very effective treatment for people with medial temporal lobe
epilepsy (MTLE), a common form
of drug - resistant
epilepsy.
Intractable
epilepsy, number
of antiepileptic
drugs used, and the number
of seizures were similar in all groups.
Nearly 30 percent
of epilepsy patients are resistant to
drug therapy, so they have the option
of surgery to remove their seizure onset zones.
But new research holds out hope that
drugs developed to treat other neurological problems — notably
epilepsy — could rein in the compulsive and blind drive to eat at the core
of the disorder.
Administering the
epilepsy drug retigabine opened the potassium channels and counteracted much
of the toxin's effects, raising hopes
of a treatment for these bites.
A technique that involves genetically engineering brain cells so that they fire in the presence
of certain
drugs has been used to treat
epilepsy in rats, and it could soon be tested in humans.
In a recent trial
of 225 patients, completed in September 2016, participants who took the
drug (along with their other
epilepsy medications) reduced their nonstop seizures by 42 percent, compared with 17 percent for those taking a placebo.
As many as three million people in the U.S. live with
epilepsy, and more than 30 percent
of them receive inadequate relief from medication, a number that persists despite the introduction
of more than a dozen new antiepileptic
drugs since 1990.
The first effective
drug for
epilepsy, potassium bromide, was introduced in the 1850s and works by inhibiting the excitability
of neurons.
A 2013 joint report from
epilepsy research organizations explained that «because the marketplace is already awash with [antiseizure
drugs], many pharmaceutical companies now refrain from the expensive enterprise
of developing new compounds.»
Using a novel combination
of technologies, including trio exome sequencing
of patient / parental DNA and genetic studies in the tiny larvae
of zebrafish, the EuroEPINOMICS RES consortium found that mutations in the gene CHD2 are responsible for a subset
of epilepsy patients with symptoms similar to Dravet syndrome — a severe form
of childhood
epilepsy that is in many patients resistant to currently available anti-epileptic
drugs.
In addition, the creation
of a zebrafish model for CHD2 encephalopathy may facilitate the discovery
of new
drugs that can treat patients with this form
of epilepsy.
«Some psychotic disorders may be induced by
drugs designed to combat effects
of epilepsy.»
The discovery opens the possibility
of designing new types
of drugs against conditions such as
epilepsy.
The study examined how many babies were diagnosed with
epilepsy and how many are on regular antiepileptic
drug treatment at two and four to eight years
of age.
Even if a lesser severity
of perinatal asphyxia is accounted for, cooling therapy has increased the number
of healthy survivors and there are very few children with
epilepsy needing
drug treatment.
Approximately one third
of people with
epilepsy still experience seizures even when receiving treatment, and currently available anti-epileptic
drugs often have side effects such as tiredness and dizziness.
At two years, seven per cent
of the children had an
epilepsy diagnosis, however, far fewer, only two per cent, were on regular antiepileptic
drugs.
I have
epilepsy and experienced many
of the ADRs my
drugs cause.
So far the CGRP
drugs work better at prevention than any
of the borrowed heart or
epilepsy drugs and have far fewer side effects.
The DNA Lounge can not sell any
of these compounds as smart
drugs because most can only be legally prescribed by doctors, and even then only for other purposes: L - Dopa for Parkinson's disease, phenytoin for
epilepsy, propanolol for certain heart conditions.
If people with focal
epilepsy don't respond well to standard
drugs, they are often offered surgery to remove the part
of the brain where the problems start.
A technique that involves genetically engineering brain cells so that they fire in the presence
of certain
drugs has been used to treat an
epilepsy - like condition in rats, and it could soon be trialled in humans.
Two newer
epilepsy drugs may not harm the thinking skills or IQs
of school - aged children whose mothers took them while pregnant — but an older
drug is linked to cognitive problems in children, especially if their mothers took high doses — according to new research from The University
of Manchester.
Participants were randomized into four different interventions that would analyze how effectively an acupuncture technique known as electroacupuncture — in which embedded needles deliver weak electrical currents — reduces incidents
of hot flashes as compared to the
epilepsy drug gabapentin, which was previously shown to be effective in reducing hot flashes for these patients.
«Unfortunately, there are no preventive therapies for any common disorder
of the human nervous system — Alzheimer's, Parkinson's, schizophrenia,
epilepsy — with the exception
of blood pressure - lowering
drugs to reduce the likelihood
of stroke,» said study author James O. McNamara, M.D., professor
of neurobiology at Duke Medicine.
In utero exposure to the
epilepsy drug VPA appears to elevate the risk to babies
of developing an autism spectrum disorder.
«Expectant mothers with
epilepsy may need to continue their
drug regime during pregnancy; this research may give them some reassurance that — provided they are prescribed topirimate and levetiracetam — they will a statistically good chance
of normal, healthy development in their children,» concluded Dr Bromley.
Babies whose mothers take the
epilepsy drug valporic acid (VPA) during pregnancy, for example, appear to have an elevated risk
of developing an autism spectrum disorder.
«From our past research, we know the ketogenic diet is effective in approximately one - third
of adults with
epilepsy who are resistant to traditional anti-seizure
drugs,» says Mackenzie C. Cervenka, M.D., associate professor
of neurology and director
of the Adult
Epilepsy Diet Center at the Johns Hopkins University School
of Medicine.
If the
drug stopped the genetically altered mice from becoming epileptic, this genetic approach would prove that inhibiting TrkB prevents the onset
of epilepsy.
The ability to temporarily disable or stimulate parts
of the brain with the flick
of a switch has led researchers to explore DBS in the treatment
of several other conditions, including
epilepsy, depression, obesity and
drug addiction.
While there is no known trigger behind seizures in people with
epilepsy, Dr. Kuebler and his lab are using their
drug - screening technique to investigate potential metabolic causes — using genetically modified, seizure - prone flies (a family
of Drosophila flies called Bang - sensitive paralytic mutants).
The precise understanding
of the mode
of action is thus the basis for developing specific
drugs for the treatment
of epilepsy and cardiac arrhythmias.
A zebrafish model
of Dravet syndrome, a severe form
of pediatric
epilepsy, may help scientists quickly find
drugs for the devastating disease.
The way to do so occurred to Olaf Blanke — a neurologist and cognitive neuroscientist at the Brain - Mind Institute, part
of the École Polytechnique Fédérale de Lausanne in Switzerland — a decade ago while he worked with an
epilepsy patient, a 43 - year - old woman with
drug - resistant seizures who had to be treated with surgery.
Topamax, an
epilepsy drug from Ortho - McNeil Pharmaceutical, has proven extremely effective on migraines in clinical trials: Half
of all patients have reported a 50 percent reduction in the frequency
of migraines, and more than a quarter have a reported 75 percent reduction.
Diseases such as
epilepsy, neuropathic pain, anxiety, depression,
drug addiction and Alzheimer's are all associated with changes in the excitability
of brain neurons.
Dravet syndrome is a severe form
of pediatric
epilepsy characterized by frequent daily
drug - resistant seizures and developmental delays.
Now, a study in the journal Brain describes what could be considered a direct «aquarium - to - bedside» approach, taking a
drug discovered in a genetic zebrafish model
of epilepsy and testing it, with promising results, in a small number
of children with the disease.
This technique, known as «responsive neurostimulation» (RNS), has proved effective for
epilepsy and an existing system has been approved by the U.S. Food and
Drug Administration for treating partial onset seizures (which affect only part
of the brain).
While the study is limited to a
drug used extensively in
epilepsy and psychiatry, the implications
of such findings extend beyond this particular
drug, indicating that FDA standards for bioequivalence are appropriate.
AES, the American Academy
of Neurology and other professional societies had opposed patients substituting antiepileptic generics for people with
epilepsy without consent
of the physician or patient out
of concern that the U.S. Food and
Drug Administration (FDA) was allowing room for too much variability across formulations.
Lamotrigine, a widely used
drug for the treatment
of epilepsy, is an ideal
drug for this assessment, says Privitera, particularly because it has also been the subject
of the noted problems with generic switches and complaints to the FDA.